Imunon shares are trading higher after Hc Wainwright & Co maintained a Buy rating on the stock and raised its price target from $12 to $13.
Portfolio Pulse from Benzinga Newsdesk
Imunon shares are trading higher following an upgrade by Hc Wainwright & Co, which maintained a Buy rating and increased the price target from $12 to $13.
April 01, 2024 | 4:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Imunon's stock price is experiencing an uplift following a positive analyst rating and an increased price target by Hc Wainwright & Co.
The positive outlook from Hc Wainwright & Co, evidenced by the maintained Buy rating and the raised price target, signals strong confidence in Imunon's potential. This typically leads to increased investor interest and can drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100